| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/21/2008 | WO2008066747A3 Electroluminescent-based fluorescence detection device |
| 08/21/2008 | WO2008061063A3 Identifying duct cancers |
| 08/21/2008 | WO2008059381A8 Methods for identifying anti-tumor and/or anti-angiogenesis drugs with rcl deoxynucleoside 5' -monophosphate n-glycosidase as the target |
| 08/21/2008 | WO2008056325A3 Process for animal species identification in samples with genetic material based on mitochondrial dna size variation |
| 08/21/2008 | WO2008048970A3 Synthetic antibodies |
| 08/21/2008 | WO2008046071A3 Compounds and methods of treating metabolic syndrome and inflammation |
| 08/21/2008 | WO2008042003A3 Method and composition for rapid viability testing of cells |
| 08/21/2008 | WO2008034622A3 A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator |
| 08/21/2008 | WO2008028210A3 Detection of bacteria |
| 08/21/2008 | WO2008026234A3 Method to identify and treat subjects resistant to acetyl salicylic acid |
| 08/21/2008 | WO2008016996A3 Methods of modulating metabolic memory |
| 08/21/2008 | WO2008010084A3 Method of prognosing recurrence of prostate cancer |
| 08/21/2008 | WO2008005310A3 Detectable nucleic acid tag |
| 08/21/2008 | WO2007106816A3 Substrates and internal standards for mass spectroscopy detection |
| 08/21/2008 | WO2007089587A3 Mechanically induced trapping of molecular interactions |
| 08/21/2008 | WO2007070642A3 Methods for increasing accuracy of nucleic acid sequencing |
| 08/21/2008 | WO2007064898A3 Methods for mapping signal transduction pathways to gene expression programs |
| 08/21/2008 | WO2007040592A8 Making nucleic acid sequences in parallel and use |
| 08/21/2008 | WO2006096459A3 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 08/21/2008 | WO2005104755A3 Artificial immune system: methods for making and use |
| 08/21/2008 | WO2004071155A3 Solid phase sequencing |
| 08/21/2008 | WO2004062608A3 Cancer comprehensive assay kit for identifying cancer protein patterns |
| 08/21/2008 | US20080201807 Gelatinization Temperature Manipulation |
| 08/21/2008 | US20080201798 Transgenic seed for propagation of disease resistant crop plants; biological pest control |
| 08/21/2008 | US20080201795 Pea Line 08550848 |
| 08/21/2008 | US20080201794 Transgenic seed for propagation of disease resistant crop plants; biological pest control |
| 08/21/2008 | US20080201793 Pea line 08530731 |
| 08/21/2008 | US20080201792 Transgenic seed for propagation of disease resistant crop plants; biological pest control |
| 08/21/2008 | US20080201790 Method and product for regulating cell responsiveness to external signals |
| 08/21/2008 | US20080201789 Variants and exons of the glyt1 transporter |
| 08/21/2008 | US20080201123 Increased activity and efficiency of expansin-like proteins |
| 08/21/2008 | US20080200653 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2008 | US20080200649 Method |
| 08/21/2008 | US20080200568 Screening for non-insulin dependent diabetes; using prostaglandin receptors, nitric oxide synthase, caspase, integrins targets; reacting with thrombospondin or metalloprotease |
| 08/21/2008 | US20080200566 Dephosphorylation of HDAC7 By Myosin Phosphatase |
| 08/21/2008 | US20080200531 CDKI pathway inhibitors as inhibitors of tumor cell growth |
| 08/21/2008 | US20080200422 Methods for reduction of adipose tissue mass |
| 08/21/2008 | US20080200416 Modulation of T cell signaling threshold and T cell sensitivity to antigens |
| 08/21/2008 | US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder |
| 08/21/2008 | US20080200410 Kits containing primers or probes; amplification and/or hybridization; early diagnosis of neoplastic disease |
| 08/21/2008 | US20080200408 Isolated recombinant nucleic acids; expression constructs; stably transformed or transfected host cells; sodium channel antagonistic analgesic agents; side effect reduction |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080200388 Stem cell factor-like proteins and uses thereof |
| 08/21/2008 | US20080200386 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/21/2008 | US20080200385 Treat urogenital, intestinal tract cancer; diagnosis, discrimination between cancerous and non-cancerous tissue; determine abundance intracellular, extracellular annexin protein from urine samples |
| 08/21/2008 | US20080200384 Quantify expression of gene encoding subtypes 1and 2 glutamate transporter, and epidermal growth factor; quantify protein level; compare to control; polymerase chain reaction using oligonucleotide primers specific to fragment of the EAAT1, EAAT2 or EGF genes; kit, antibody binds antigenic determinants |
| 08/21/2008 | US20080200381 Diagnostic assays for detecting, treating bone, cartilage formation, resorption, osteoporosis, bone fractions; determine level of gene expression of CRLF-1 and/or MMP23 in biological sample |
| 08/21/2008 | US20080200379 Diagnostic markers of human female infertility |
| 08/21/2008 | US20080200374 Mutational derivatives of microcin j25 |
| 08/21/2008 | US20080200368 Peptide composition |
| 08/21/2008 | US20080200348 A solid support having in a pre-defined order detectable markers representative of a saccharide or saccharide sequence or fragment (enzyme, a metal, a radioactive agent, biotin or a fluorescent agent); Multi-element Amorphous Silicon Detector Array; very large scale integrated circuit chip |
| 08/21/2008 | US20080200346 Method and device |
| 08/21/2008 | US20080200341 Biopolymer array assays between surface bound binding agents or probes and target molecules in solution; improved seals inhibit solvent evaporation; improved accuracy |
| 08/21/2008 | US20080200340 Dispersing the probe beads in a thixotropic agent, scanning for a detectable signal, isolating the target biomolecule; high throughput assays |
| 08/21/2008 | US20080199936 FEN Endonucleases |
| 08/21/2008 | US20080199904 Device comprising medium for supporting growth of a microorganism and at least one calorimetric sensing element for use in visual imaging of chemoresponsive dyes and determining concentration and identity of micoorganism in fluid |
| 08/21/2008 | US20080199903 Biological indicator |
| 08/21/2008 | US20080199902 Biosensor For Determining The Biochemical Oxygen Demand (Bod) By Respirometry |
| 08/21/2008 | US20080199901 Method of monitoring microbiological activity in process streams |
| 08/21/2008 | US20080199900 Disposable Device For One Or More Introductions, Treatment And Sampling Of Biological Material From At Least One Of The Separation Phases Present Within The Device, Under Sterility Conditions and Constant Pressure |
| 08/21/2008 | US20080199899 Method For Screening Modulators of Mitochondrial Functioning and New Modulators Obtained |
| 08/21/2008 | US20080199898 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology |
| 08/21/2008 | US20080199897 Reporter molecules |
| 08/21/2008 | US20080199896 Using inhibitors of target of rapamycin (TOR) gene products as therapeutic agent in treatment of cardiovascular disorders |
| 08/21/2008 | US20080199895 Mixture comprising adenosine triphosphatase for use in identifying modulators for treatment and prevention of congestive heart failure |
| 08/21/2008 | US20080199894 Using resistance values to determine blood glucose concentration; managing diabetes |
| 08/21/2008 | US20080199893 Medical Biosensor By Means of Which Biological Liquids are Analyzed |
| 08/21/2008 | US20080199890 Methods of Determining Cellular Chemosensitivity |
| 08/21/2008 | US20080199883 Protein kinase (PAPAP) for use in diagnosis, prevention and treatment of nervous system disorders |
| 08/21/2008 | US20080199878 Nucleotide sequences comprising internal transcribed spacer ribosomal region for use in classification of staphylococcus |
| 08/21/2008 | US20080199877 Gyrase specific probe for diagnosing microorganismal infection |
| 08/21/2008 | US20080199876 MutS homolog 5 (MSH5) variant for use as diagnostic/ prognostic indicator of cell proliferative disorders |
| 08/21/2008 | US20080199875 Unsymmetrical cyanine dimer compounds and their application |
| 08/21/2008 | US20080199874 Controllable strand scission of mini circle dna |
| 08/21/2008 | US20080199873 Companion diagnostic assays for cancer therapy |
| 08/21/2008 | US20080199872 Method and Kit for Analyzing a Target Nucleic Acid Sequence |
| 08/21/2008 | US20080199871 Using particle beam variance as analytical tool in determining orders of preferential nucleotide sequence |
| 08/21/2008 | US20080199870 Compositions and methods for the identification of inhibitors of protein synthesis |
| 08/21/2008 | US20080199869 Novel mycobacterium tuberculosis protein composition |
| 08/21/2008 | US20080199868 Massive parallel method for decoding DNA and RNA |
| 08/21/2008 | US20080199867 Multiple mode multiplex reaction quenching method |
| 08/21/2008 | US20080199866 Using presence of restriction fragment length polymorphism in desmocollin 2 (DSC2) gene as diagnostic/prognostic indicator of depression |
| 08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
| 08/21/2008 | US20080199864 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 08/21/2008 | US20080199863 Oligonucleotide probes specific to bacterial ribosomal RNA for use as screening tool in detection antibiotic resistant microorganisms |
| 08/21/2008 | US20080199862 Multicompartment device comprising nucleic acid array for detection of preferential gene sequences/segments in solution |
| 08/21/2008 | US20080199861 Multicomponent device comprising layered substrates, heating unit and imaging sensor for use in amplifying preferential DNA sequences |
| 08/21/2008 | US20080199860 Variants of the alpha 1 subunit of human ampk |
| 08/21/2008 | US20080199859 Identification Marker Responsive to Interferon Therapy for Renal Cell Cancer |
| 08/21/2008 | US20080199858 Transgenic plant comprising vector which expresses estrogen receptors for use as tool in identifying environmental hormones |
| 08/21/2008 | US20080199857 Increasing the specificity of nucleic acid hybridization via incubation of hybridizing pairs in solutions containing 3-(cyclohexylamino)-1-propanesulfonic acid (CAPS), 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS) and/or 2-(cyclohexylamino)ethane sulfonate (CHES) |
| 08/21/2008 | US20080199856 Probe for Diagnosis of Marfan Syndrome and a Method for Screening Using the Probe |
| 08/21/2008 | US20080199855 Using tumor marker expression as diagnostic and/or evaluative tool in detecting glioblastoma (GBM) |
| 08/21/2008 | US20080199854 Methods and compositions for identifying RNA-binding proteins |
| 08/21/2008 | US20080199853 Methods and Compositions for Diagnosis and Monitoring Auto Immune and Chronic Inflammatory Diseases |
| 08/21/2008 | US20080199852 Using presence of E6 and E7 viral proteins as diagnostic indicator urogenital cell proliferative disorders |
| 08/21/2008 | US20080199851 Lateral flow device comprising bibulous strip containing one or more discrete bands of pRNA non-diffusively bound to support, each band capable of indirectly capturing different analyte with high specificity; screening for pathogenic virus, enzymes and/or proteins |
| 08/21/2008 | US20080199850 Egfr Dependent Modulation of Chemokine Expression and Influence on Therapy and Diagnosis of Tumors and Side Effects Thereof |
| 08/21/2008 | US20080199849 Using embryonic stem cell culture to generate cardiac, bone and skin grafts; regenerative medicine; tissue engineering |
| 08/21/2008 | US20080199847 Comparing metabolite expression in hepatocyte chimeric and non-chimeric animal models; drug screening and liver function |